What is it about?
Indian experience of 4-n-butylrecorsinol cream on face excess pigmentation conditions
Featured Image
Why is it important?
This is first Indian clinical trial of 4-n-butylrecorsinol cream
Perspectives
This data showed that 4-n-butylrecorsinol is safe, and highly effective in patients with melasma
Dr Manjula Shamanna
Microlabs
Read the Original
This page is a summary of: Assessment of efficacy, safety, and tolerability of 4-n-butylresorcinol 0.3% cream: an Indian multicentric study on melasma, Clinical Cosmetic and Investigational Dermatology, January 2016, Dove Medical Press,
DOI: 10.2147/ccid.s89451.
You can read the full text:
Contributors
The following have contributed to this page
